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Abstract
Melanomas are the most common oral malignancy in dogs. Cell proliferation and connexin expression has been shown 
to differ in canine melanotic and amelanotic oral melanomas. This study aimed to analyze the c-Kit protein expression in 
melanotic and amelanotic melanomas from canine buccal cavity. A total of 34 canine buccal melanomas (19 melanotic 
and 15 amelanotic).were collected. The amelanotic melanomas presented faster evolution and higher incidence of 
metastasis than melanotic tumors. A significantly higher number of c-Kit positive cells were observed in amelanotic 
neoplasms. In addition, the intensity of c-Kit immunolabeling was predominantly stronger in amelanotic melanomas. 
These results confirm a potential role for c-Kit in canine oral melanomas with clear differences in expression patterns 
between the two histological types of tumor, melanotic and amelanotic. This study highlights the importance of a 
detailed study of c-Kit mutations in canine oral melanomas to better understand the molecular mechanisms implicated 
in the development of this disease. 
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Resumo
Melanomas são as mais frequentes neoplasias malignas da cavidade bucal de cães. Sabe-se que a proliferação de células 
e expressão de conexina diferem em melanomas melanóticos e amelanóticos da cavidade bucal de cães. Este estudo 
analisou a expressão da proteína c-Kit em melanomas melanóticos e amelanóticos da cavidade bucal canina. Um total 
de 34 melanomas bucais caninos (19 melanóticos e 15 amelanóticos) foram coletados. Os melanomas amelanóticos 
apresentaram evolução mais rápida e maior incidência de metástase. Foi constatado um número significativamente 
maior de células positivas para c-Kit em neoplasias amelanóticas. Além disso, a intensidade de imunomarcação de c-Kit 
foi predominantemente mais forte em melanomas amelanóticos. Estes resultados confirmam um papel potencial para 
c-Kit em melanomas orais caninos, com diferenças claras em padrões de expressão entre os dois tipos histológicos de 
tumor, melanóticos e amelanóticos. Este trabalho destaca a importância de um estudo detalhado das mutações c-Kit 
em melanomas orais caninos para ser possível a melhor compreensão dos mecanismos moleculares envolvidos no 
desenvolvimento da doença.
Palavras-chave: Melanoma melanótico. Melanoma amelanótico. C-kit. Imuno-histoquimica. Cães.
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Melanomas account for 7% of all malignant canine 
tumors (SMITH; GOLDSCHMIDT; MCMANUS, 
2002) and are the most common oral malignancy 
in dogs (BERGMAN, 2007). They are characterized 
by local invasion and high rate of distant metastases 
(PROULX et al., 2003). Because of the prevalence 
and aggressive nature of oral cavity tumors in dogs, 
studying their molecular characteristics is mandatory. 
The primary factors that determine the biological 
behavior of an oral melanoma in dogs are site, size, 
stage and histologic parameters. (SPANGLER; 
KASS, 2006). Based only on histological features, 
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the melanotic malignant neoplasm is classified by 
the Veterinary WHO bulletin in three subtypes of 
cell morphologic aspects: epithelioid or polygonal, 
spindle or fibromatous and mixed - epithelioid and 
spindle (GOLDSCHMIDT et al., 1998). Another 
classification is based on the ability of melanoma cells 
to produce or not melanin, classifying melanomas 
into melanotic and amelanotic types, respectively. 
However, the combined lack of pigmentation and the 
indistinct cellular morphology of many oral malignant 
melanomas often make definitive diagnosis difficult 
when based on microscopic examination alone 
(SMEDLEY et al., 2011a). Although the histological 
appearance has not been used as prognostic value 
(SMEDLEY et al., 2011b), the lack of melanin appears 
to play an important role in prognosis due to the 
signals of higher aggressiveness seen in amelanotic 
melanomas. (TAJIMA; URA-ISHIKO; HAYASHI, 
1996; CHOI; KUSEWITT, 2003). Canine melanotic 
and amelanotic buccal melanomas have recently 
been shown to differ regarding cell proliferation and 
connexin expression (TEIXEIRA et al., 2014), and 
amelanotic buccal melanomas were considered more 
aggressive than their melanotic counterparts.
The c-Kit is a tyrosine kinase receptor whose aberrant 
activation is implicated in a variety of tumors. Its 
ligand, the glycoprotein stem cell factor (SCF), recruits 
and activates a high number of intracellular signal 
transducers implicated in tumor progression, such as 
phosphoinositide-3 kinase (PI3K), AKT, Src, mitogen-
activated protein kinase (MAPK), janus kinase (JAK), 
transcription factors (e.g. STAT) and phospholipase 
(PL) Cγ. (SMALLEY; SONDAK; WEBER, 2009). 
The role of c-Kit signaling in melanoma is 
controversial. Although c-Kit activity is critical 
to melanocyte development and migration, its 
expression tends to be reduced in most melanomas, 
mainly in the invasive and metastatic types (NATALI 
et al., 1992). Transfection of c-Kit into c-Kit-negative 
highly metastatic human melanoma cells significantly 
inhibited tumor growth and metastasis in nude mice 
(HUANG et al., 1998). Exposure of c-Kit positive 
melanoma cells to SCF in vitro and in vivo triggered 
apoptosis of these cells but not of normal melanocytes. 
Loss of c-Kit receptor may thus allow melanoma cells 
to escape SCF/c-Kit-mediated apoptosis (HUANG 
et al., 1998). In addition, Newmann et al. (2012) 
have shown that Kit expression anywhere within 
the resected mucosal melanomas correlated with 
significantly longer survival. 
 The aim of the present study was to analyze the 
c-Kit protein expression in melanotic and amelanotic 
melanomas from oral cavity of dogs as a first step to 




Canine buccal melanoma samples were obtained 
from the Laboratory of Comparative Dentistry, 
Service of Surgery, Veterinary Hospital of the 
School of Veterinary Medicine and Animal Science, 
University of São Paulo, Brazil. Age, gender, melanoma 
location in buccal cavity and clinical characteristics, 
such as metastasis signal in lymph nodes or lungs, 
were recorded. All animals underwent radiological 
evaluation and chest X-ray diagnosis in order to verify 
the presence of lung metastasis. All dogs were then 
submitted to surgery in order to remove the tumor. 
The term tumor evolution refers to the time period 
reported by the owners to the clinician that they 
noticed the tumor mass shown in tables 1 and 2. This 
study has been approved by the Committee on Ethics 
for the Use of Animals of the School of Veterinary 
Medicine and Animal Science of the University of São 
Paulo, Brazil. The survival time of the animals after 
the surgical procedure has been properly analyzed by 
the Kaplan Meyer curve. 
Tumor samples and histopathological analysis
Tumor samples were harvested after the surgical 
procedures with prior permission of the animal 
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owners. A total of 34 melanomas from the oral cavity 
of dogs were collected, consisting of 19 melanotic 
and 15 amelanotic specimens. Representative slices 
of the tumors were properly fixed in neutral buffered 
formalin (10%). The 34 samples were routinely 
processed for embedding in paraffin wax. The 5 µm 
thick sections were stained with hematoxylin and 
eosin and were examined by two pathologists using 
a Nikon Eclipse E-800 microscope (Nikon, Tokyo, 
Japan). Digital photomicrographs were captured by 
Image ProPlus software (Media Cybernetics, Silver 
Spring, MD, USA). All melanomas were classified 
Table 1 –  Characterization of patients with melanotic melanoma. Clinical and tumor evolution – School of Veterinary 
Medicine and Animal Science of the University of São Paulo – 2011
Case Age∕years Gender Location Tumor Evolution Metastasis
1 12 M Gingiva Progression in 3 months No
2 11 M Gingiva Progression in 5 months No
3 14 F Gingiva Progression in 4 months Lung
4 8 M Gingiva Progression in 5 months No
5 8 M Gingiva Progression in 6 months No
6 9 F Gingiva Progression in 3 months No
7 11 F Gingiva Progression in 1 month No
8 12 M Gingiva Progression in 3 months No
9 10 M Gingiva Progression in 4 months No
10 8 F Gingiva Progression in 14 days No
11 12 M Gingiva Progression in 4 months No
12 8 M Gingiva Progression in 2 months No
13 9 F Gingiva Progression in 3 months No
14 10 F Gingiva Progression in 3 months No
15 11 F Gingiva Progression in 5 months No
16 11 M Lips Progression in 6 months No
17 9 M Lips Progression in 2 months No
18 7 M Palate Progression in 3 months Nodes∕ Lung
19 10 M Palate Progression in 5 months Node
Table 2 – Expression of c-Kit by immunohistochemistry (IHC) in melanotic and amelanotic melanomas – School of 
Veterinary Medicine and Animal Science of the University of São Paulo – 2011
Tumor type Score of C-Kit Expression % Score C-Kit Expression % C-Kit Membrane Location % C-Kit Cytoplasm Location
Melanotic 
melanoma (-) 36.9% ------- --------
 (+) 36.9 75% 50%
 (++) 15.8% 25% 25%
 (+++) 10.5% ------- 25%
Amelanotic 
melanoma (-) 33.4% ------------ ----------
 (+) 6.7% 12.5% ---------
 (++) 20% 25% 50%
 (+++) 39.9% 62.5% 50%
according to veterinary WHO classification of tumors 
(GOLDSCHMIDT et al., 1998). 
Immunohistochemistry 
Antibodies and respective dilutions used in this 
study are presented in table 3. Immunohistochemistry 
for HMB45 and Melan-A was used in order to prove 
that amelanotic tumors were indeed melanomas. 
Both types of melanomas were submitted to 
immunohistochemistry for c-Kit. In order to perform 
immunohistochemistry in melanotic melanomas, 
removal of melanin was necessary. Therefore, slides 
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were submitted to antigen retrieval by boiling them in 
citrate buffer in a microwave oven after deparaffinization 
and rehydration, as described previously, with 
modifications (HSU; RAINE; FANGER, 1981). After 
antigen retrieval, slides were immersed in KMnO4 
solution for 30 min, washed in phosphate buffered 
saline (PBS) for 5 min and immersed in a solution 
containing oxalic acid for 1 min. The LSAB kit (Dako, 
California) was used and stained by diaminobenzidine 
(DAB) with modifications (SULAIMON; KITCHELL; 
EHRHART, 2002). Negative controls were performed 
by omitting the primary antibody in a tissue slide 
during immunohistochemical reaction.
Semi-quantitative c-Kit analyses
The immunohistochemical labeling was evaluated 
semi-quantitatively and quantitatively. The intensity 
of the immunolabeling is represented by the number 
of positively labeled melanoma cells and was scored 
as follows: (-) no positive cells, (+) less than 30% 
of positive cells; (++) from 30% to 60% of positive 
cells and (+++) more than 60% of positive cells. 
The positive cells were then quantified in an image 
analysis system. For each sample, 1,000 cells were 
counted in 40X magnification field, with positive and 
negative cells recorded. The procedure was performed 
manually in the Image Pro Plus System (version 4.5 
of Windows, 2002 edition). The percentage of c-Kit 
positive cells was then calculated for each tumor case.
Quantitative c-Kit analyses
Positive cells were quantified in melanoma slides 
submitted to c-Kit immunohistochemical labeling. 
The subcellular localization of the receptor, whether 
Table 3 –  Antibodies used for immunolabeling of canine melanomas – School of Veterinary Medicine and Animal 
Science of the University of São Paulo – 2011
Antibody Clone Supplier Dilution Antigen Retrieval
HMB45 HMB45 Dako 1:50 Citrate Buffer (pH 6) 12’ 98°C microwave
Melan-A A103 Dako 1:25 Citrate Buffer (pH 6) 12’ 98°C microwave
c-Kit A4502 Dako polyclonal Rabbit 1:80 Citrate Buffer (pH 6) 12’ 98°C microwave
in the cytoplasm or the membrane, was also analyzed. 
For each sample, 1,000 cells were counted in 40X 
magnification field, with positive and negative cells 
recorded. The procedure was performed manually in 
the Image Pro Plus System (version 4.5 of Windows, 
2002 edition). The percentage of positive cells and 
cellular localization of c-Kit were registered for each 
tumor case, and then the mean and standard deviations 
were obtained for melanotic and amelanotic groups, 
respectively.
Statistical Analysis
Statistical analysis was performed with Student’s 
t-test. Continuous variables were expressed as mean 
± standard deviation or as median if abnormal. 
This statistic test was used to verify the existence of 
difference in c-Kit stained cells and localization in the 
cells between two groups, melanotic and amelanotic 
melanomas. A two-tailed P value < 0.05 was 
considered to express statistical significance. A non-
parametric analysis among groups was performed 
using the Kruskal–Wallis test (Prism version 5, 
Graphpad Software) for the Kaplan Meyer curve.
Results
Amelanotic melanomas present faster evolution and 
higher metastasis rate
Old male dogs were preferentially affected by 
both melanotic and amelanotic melanomas and the 
gingival area were predominantly affected. (Tables 1 
and 4). The amelanotic melanomas presented faster 
evolution and a higher incidence of metastasis than 
melanotic tumors (Tables 1 and 4). This study included 
34 tissues of primary oral melanomas (19 melanotic 
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Table 4 – Characterization of patients, with amelanotic melanoma. Clinical and tumor evolution – School of Veterinary 
Medicine and Animal Science of the University of São Paulo – 2011
Case Age∕years Gender Location Tumor Evolution Metastasis
1 10 F Gingiva Progression in 3 months No
2 11 M Gingiva Progression in 3 months No
3 7 F Gingiva Progression in 4 months No
4 13 M Gingiva Progression in 3 months No
5 4 F Gingiva Progression in 15 days LymphNode
6 12 M Gingiva Progression in 3 months No
7 8 M Gingiva Progression in 2 months Node
8 10 F Gingiva Progression in 2 months Node
9 1 M Gingiva Progression in 1 months LymphNode / Lung
10 9 M Gingiva Progression in 2 months Node
11 11 F Gingiva Progression in 50 days No
12 4 M Gingiva Progression in 1.5 month No
13 8 M Lip Progression in 4 months No
14 11 F Lip Progression in 4 months No
15 4 M Lip Progression in 1.5 month No
and 15 amelanotic). Th e diagnosis was confi rmed by 
HMB45 and Melan-A immunostaining.
Amelanotic melanomas show greater number of 
c-Kit positive cells
Th e both tumors (melanotic and amelanotic) 
presented immunopositivity for c-Kit in the 
cytoplasm and membrane locations, as shown in 
fi gure 1. However, amelanotic tumors had the greatest 
number of positively immunostained cells (Figure 
2). Among the melanotic melanomas, seven tumors 
were negative for c-Kit positivity, seven samples were 
(+); three tumors presented moderate (++), and 
two tissues showed strong intensity (+++) (Table 
2). Among the amelanotic group, fi ve tumors were 
negative; only one tumor showed weak staining (+), 
three melanomas had moderate staining (++), and six 
tumors had strong staining (+++) (Table 2). Regarding 
the location of c-Kit labeling in melanotic melanoma 
cells, the predominant location was the cytoplasm. In 
contrast, there was no signifi cant diff erence between 
cytoplasmic and membrane locations in amelanotic 
melanoma cells, as shown in table 2.
Figure 1 – Immunohistochemical labeling 
for c-Kit (original magnifi cation 
X 40). (A) Strong cytoplasmic 
immunostaining in melanocytic 
melanoma. (B) Membrane and 
cytoplasmic c-kit immunostain-
ing in melanotic melanoma. (C) 
Weak cytoplasmic c-kit immu-
nostaining in amelanotic mela-
noma. (D) Strong cytoplasmic 
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Figure 2 – Statistical analysis was performed with Stu-
dent’s t-test to compare the number of positive 
cells of c-Kit between melanotic and amelanotic 
tumors. Amelanotic melanoma has shown sig-
nifi cantly higher number of c-Kit positive cells. 
(P = 0,0177)
Source: (TEIXEIRA, 2011)
Th e c-Kit expression has no infl uence 
on survival time
Th e survival time curves for each melanotic and 
amelanotic tumors including the c-Kit expression 
were compared in fi gure 3. Th e statistical analysis for 




Since the early 1990s, some evidence has been 
gathered showing that c-Kit plays an important 
role in melanogenesis (SULAIMON; KITCHELL; 
EHRHART, 2002). Recently, the activation of the 
c-Kit proto-oncogene has been frequently observed in 
malignant melanomas (WITTE, 1990). Some genetic 
studies have demonstrated that the natural occurrence 
of inactivating mutations in the proto-oncogene c-Kit 
that impair the kinase activity of this receptor, leading 
to various developmental disorders and resulting in 
amelanotic congenital patches of white skin (HIDA et 
al., 2009). Several studies have also shown that c-Kit 
infl uences the migration, proliferation and survival 
of melanocytes (SPRITZ; GEIBEL; HOLMES, 1992; 
LENNARTSSON et al., 2005). Th is fact supports 
the hypothesis that c-Kit plays an important role in 
melanomas. Based on these statements, the current 
study aimed to analyze the expression of c-Kit protein 
in melanotic and amelanotic melanomas from oral 
cavity of dogs in order to better understand the 
function of this receptor in tumor aggressiveness. 
Th e results showed faster tumor evolution among 
animals with amelanotic melanomas and higher 
metastasis incidence than compared to animals 
bearing melanotic tumors. Nonetheless, the etiology 
and pathogenesis of amelanotic tumors has been 
unclear or not completely understood. Signifi cant 
diff erences between melanotic and amelanotic 
melanomas in c-Kit expression analysis have been 
observed, with a greater number of c-Kit labeled 
cells in amelanotic tumors. Unlike amelanotic 
melanomas that have shown cytoplasmic and 
membrane location patterns for c-Kit, melanotic 
tumors have presented a predominant cytoplasmic 
location for the receptor. It has been proposed that 
cytoplasmic immunoreactivity for c-Kit might be 
due to a non-mature form of the protein rather 
than a proteolytically processed molecule, which 
would be the active membranous receptor form 
(GRICHNIK, 2006). In physiologic conditions, the 
Figure 3 – Th e Kaplan Meyer curve for each melanotic 
and amelanotic tumor including the c-Kit ex-
pression were compared. Statistical analysis for 
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signaling cascade is initiated by transmembraneous 
receptor tyrosine kinases (RTK), such as c-Kit, 
and functions for signal transmission from the cell 
membrane to the nucleus (TORRES-CABALA et 
al., 2009). Some studies have indicated that most of 
the mutations in c-Kit affect the juxta-membrane 
region of the protein, preventing its positioning in 
the plasmatic membrane (JIANG et al., 2008; HELD 
et al., 2011). Although the authors have not analyzed 
any mutations in the juxta-membrane region of 
c-Kit in this study, the hypothesis of a disruption in 
the positioning of c-Kit in the plasmatic membrane 
leading to inactive forms of the receptors in 
melanotic melanomas may be considered. 
The authors observed a moderate and strong labeling 
for c-Kit in amelanotic melanomas, disagreeing 
with the results of Morini et al. (2004), who showed 
weak to moderate CD117 immunolabeling pattern. 
A mutational study of c-Kit in human mucosal 
melanomas demonstrated a correlation between a 
stronger expression of the protein and the presence of 
mutations in exon 11 of c-Kit, suggesting a pertinent 
role for c-Kit mutations in the development of oral 
mucosal melanoma (RIVERA et al., 2008). According 
to Satzger et al. (2008), there is a significantly higher 
immunohistochemical expression of c-Kit in human 
mucosal melanomas that harbor a potentially 
activating Kit mutation as compared with tumors 
without this mutation. The analysis of c-Kit expression 
and exon 11 mutations in canine oral malignant 
melanomas was performed and although 20 of 39 
cases were positive for c-Kit protein, there was no 
significant difference between the receptor expression 
and overall survival. Moreover, polymerase chain 
reaction amplification and sequencing of c-Kit 
exon 11 in 17 samples did not detect any mutations 
(KINOSHITA et al., 2003; MURAKAMI et al., 2011). 
In this particular case, two aspects should be taken 
into account. The authors have not classified the 
melanomas in melanotic or amelanotic categories and 
have not analyzed mutations in other exons, leaving 
some points unclear.
As amelanotic melanomas have been associated 
with a more aggressive type and poor prognosis 
(RIVERA et al., 2008) and the results have indicated 
a predominance of strong immunostaining of c-Kit in 
this type of melanoma in dogs, this could be linked 
to c-Kit mutation. However, a study conducted by 
Murakami et al. (2011) has shown no correlation 
between c-Kit expression and overall survival. 
Although this study has not classified the tumors 
into melanotic and amelanotic categories, the data 
for melanotic and amelanotic tumors in the current 
study have also not identified any correlation between 
survival and c-Kit expression. Thus, the aggressiveness 
of amelanotic melanomas still appears to be related to 
the lack of melanin and a differentiation issue, rather 
than to c-Kit expression. 
Melanomas are not genetically and histologically 
homogeneous and may follow different pathways to 
oncogenic transformation (SMALLEY; SONDAK; 
WEBER, 2009). One of these pathways may be 
through the signaling of c-Kit, which appears to play 
a role in the aggressiveness of oral mucosal melanoma 
(RIVERA et al., 2008). The answer to this question 
could be hidden in the lack of melanin in some 
melanomas. It is probable that the expression of the 
mutant c-Kit was associated with lower pigmentation 
of melanocytes, presumably caused by down 
regulation of the tyrosine gene expression (LUO et 
al., 1995; ALEXEEV, YOON, 2006). In summary, 
c-Kit appears to play an important role in melanoma 
biology. However, further studies are required to 
confirm this hypothesis.
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